Related Experiment Videos

Penetrance of familial hypertrophic cardiomyopathy

P Charron1, L Carrier, O Dubourg

  • 1Service de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France.

Genetic Counseling (Geneva, Switzerland)
|January 1, 1997
PubMed

Insights

Familial hypertrophic cardiomyopathy (FHC) penetrance is incomplete at 69% and increases with age, reaching 95% in individuals over 50. Penetrance is also higher in males compared to females.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Research

Background:

  • Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant cardiac condition.
  • The penetrance of FHC has been a subject of ongoing debate.
  • Previous assessments of FHC penetrance have not utilized large, genotyped populations.

Purpose of the Study:

  • To re-evaluate the penetrance of FHC in a large, genotyped cohort.
  • To assess FHC penetrance based on age and sex.
  • To analyze penetrance across different mutations within families.

Main Methods:

  • Studied 178 individuals from ten families with known FHC mutations.
  • Genetically identified 90 affected individuals carrying 9 different mutations in 3 genes.
  • Assessed penetrance using echocardiographic and electrocardiographic criteria.

Main Results:

  • Overall FHC penetrance was found to be incomplete at 69%.
  • Penetrance demonstrated a clear age-related pattern: 55% (10-29 years), 75% (30-49 years), and 95% (over 50 years).
  • Penetrance was significantly higher in males (77%) compared to females (58%), with an odds ratio of 3.98.

Conclusions:

  • FHC penetrance is incomplete and significantly influenced by age and sex.
  • These findings have crucial implications for genetic counseling regarding FHC.
  • The results also provide valuable insights for future genetic linkage analyses in FHC.

Related Concept Videos